Clinical Trial Update: A Two-dose Primary Vaccination Study of a Tetravalent Dengue Virus Purified Inactivated Vaccine vs. Placebo in Healthy Adults [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating safety and immunogenicity of a two-dose tetravalent dengue virus purified inactivated vaccine vs placebo in healthy adults; the study i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dengue Fever

Drugs mentioned

• Tetravalent dengue virus purified-inactivated vaccine (Tetravalent dengue virus purified-inactivated vaccine)

Snippet

Sponsor: U.S. Army Medical Research and Development Command | Conditions: Dengue Fever | Phase 1 | Status: COMPLETED | Results posted: 2019-01-25